Ascendis Pharma A (ASND) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Ascendis Pharma A (ASND) over the last 14 years, with Q3 2025 value amounting to -$630.2 million.
- Ascendis Pharma A's Enterprise Value rose 825.74% to -$630.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$630.2 million, marking a year-over-year increase of 825.74%. This contributed to the annual value of -$605.6 million for FY2024, which is 4091.52% down from last year.
- Per Ascendis Pharma A's latest filing, its Enterprise Value stood at -$630.2 million for Q3 2025, which was up 825.74% from -$559.2 million recorded in Q2 2025.
- In the past 5 years, Ascendis Pharma A's Enterprise Value ranged from a high of -$278.6 million in Q2 2024 and a low of -$849.4 million during Q1 2022
- In the last 5 years, Ascendis Pharma A's Enterprise Value had a median value of -$544.8 million in 2025 and averaged -$556.6 million.
- Its Enterprise Value has fluctuated over the past 5 years, first soared by 4035.83% in 2023, then plummeted by 10074.2% in 2025.
- Quarter analysis of 5 years shows Ascendis Pharma A's Enterprise Value stood at -$515.7 million in 2021, then increased by 8.65% to -$471.1 million in 2022, then grew by 8.77% to -$429.8 million in 2023, then plummeted by 39.13% to -$597.9 million in 2024, then fell by 5.4% to -$630.2 million in 2025.
- Its Enterprise Value stands at -$630.2 million for Q3 2025, versus -$559.2 million for Q2 2025 and -$544.8 million for Q1 2025.